Steward Financial Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Steward Financial Group’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,000	Closed	-$29K	–	978
2022 Q4	$29K	Buy	+2,000	New	+$27.7K	0.01%	98
2022 Q3	–	Sell	-2,000	Closed	-$13K	–	1486
2022 Q2	$13K	Hold	2,000	–	–	0.01%	210
2022 Q1	$11K	Hold	2,000	–	–	0.01%	206
2021 Q4	$9K	Buy	+2,000	New	+$12.4K	0.01%	164

Steward Financial Group's AVEO Position: Q1 2023 in Review

Steward Financial Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 2,000 shares — an estimated $29K sold.

Steward Financial Group first reported a position in AVEO in Q4 2021 and held it in 4 quarters. The position peaked at $29K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Steward Financial Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Steward Financial Group sold 2,000 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $29K.
Steward Financial Group first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2021 and held it in 4 quarters.
Steward Financial Group's AVEO Pharmaceuticals, Inc. position peaked at $29K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Steward Financial Group's 13F filing for Q1 2023, filed 5 May 2023.